What does a radioactive thyroid scan showing areas of both increased and suppressed uptake indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Radioactive Thyroid Scan with Mixed Increased and Suppressed Uptake

A radioactive thyroid scan showing both areas of increased uptake and suppressed uptake is pathognomonic for toxic multinodular goiter, where autonomous hyperfunctioning nodules ("hot" nodules) suppress the surrounding normal thyroid tissue. 1

Pattern Recognition and Diagnosis

The characteristic pattern you describe represents:

  • Multiple "hot" areas (increased uptake) corresponding to autonomous hyperfunctioning nodules that are producing excess thyroid hormone independently of TSH control 1, 2
  • Intervening "cold" areas (suppressed uptake) representing normal thyroid tissue that has been suppressed by the autonomous nodules through negative feedback on TSH 1, 3

This heterogeneous pattern with multiple areas of variable activity distributed throughout the gland is diagnostic of toxic multinodular goiter when TSH is suppressed 3, 2. The autonomous nodules function independently due to somatic activating gain-of-function mutations in the TSH receptor 2.

Differential Diagnosis Considerations

While toxic multinodular goiter is the most common cause of this pattern, other rare scenarios can produce mixed uptake:

  • Marine-Lenhart syndrome: Coexistence of Graves' disease with an autonomously functioning nodule, showing diffuse uptake throughout the gland with superimposed focal increased uptake in the autonomous nodule 4
  • Non-toxic multinodular goiter (euthyroid state): Shows heterogeneous uptake with variable activity but without suppression of intervening tissue, as TSH is not suppressed 3

The key distinguishing feature is the biochemical context: toxic multinodular goiter presents with suppressed TSH, elevated free T4/T3, and negative TSH receptor antibodies (ruling out Graves' disease) 1, 2.

Clinical Implications for Management

Definitive treatment planning should prioritize thyroidectomy as the preferred approach in younger patients or those with compressive symptoms, as it provides immediate cure and rapid restoration of normal thyroid function. 1

Alternative treatment options include:

  • Radioactive iodine therapy: The scan pattern helps calculate the appropriate dose based on the volume of hyperfunctioning tissue; the goal is to achieve euthyroid status (not hypothyroidism as in Graves' disease) 3, 2
  • Antithyroid medications: Typically used as a bridge to definitive therapy rather than long-term management 2

Important Caveats

  • The scan has low positive predictive value for malignancy and cannot determine which nodules require biopsy 3. Any suspicious nodules on ultrasound should still undergo fine-needle aspiration regardless of their uptake pattern 3.
  • Coexisting thyroid cancer can be missed if ultrasound evaluation is skipped and only scintigraphy is performed 3. Always perform ultrasound first in the diagnostic algorithm, even when TSH is suppressed 3.
  • The pattern can evolve with treatment: autonomous nodules may change from "hot" to "cool" during antithyroid drug therapy as TSH levels normalize 4.

References

Guideline

Toxic Multinodular Goiter

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The Role of Nuclear Medicine in the Clinical Management of Benign Thyroid Disorders, Part 1: Hyperthyroidism.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2021

Guideline

Thyroid Imaging Selection Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the next step in managing a patient with a low Thyroid-Stimulating Hormone (TSH) level, normal Triiodothyronine (T3) and Thyroxine (T4) levels, and a radioactive iodine uptake scan showing multiple areas of increased and suppressed uptake?
What is the appropriate treatment plan for hyperthyroidism?
For a patient with hyperthyroidism and an enlarged hypervascular thyroid gland, should I consult an Ear, Nose, and Throat (ENT) specialist or an endocrinologist?
What is the diagnosis and treatment for a patient with normal Thyroid-Stimulating Hormone (TSH) levels but elevated Triiodothyronine (T3) and Thyroxine (T4) levels?
What is a typical T4 (thyroxine) level in a patient with hyperthyroidism?
Is it safe to prescribe Rexulti (brexpiprazole) with 225 mg of venlafaxine (Effexor)?
What is the appropriate management for a patient with apex pulse deficit?
Is the proposed procedure with possible fat graft and plastics for complex closure medically indicated for a patient with a history of sphenoid orbital lesion, status post resection, with ongoing eye swelling, intermittent pain, and concern for recurring preorbital cellulitis?
Can low dose Adderall (amphetamine and dextroamphetamine) be used with Rexulti (brexpiprazole)?
Is this medication/surgery medically indicated for a patient with acute compression fractures of T7 and T8, posterior element involvement, and central stenosis, who underwent percutaneous posterior spinal fusion/instrumentation and laminectomy?
Can clobetasol (corticosteroid) be used on a wound with a cover dressing for hypergranulated tissue?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.